Status:
WITHDRAWN
Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children
Lead Sponsor:
Osaka University
Conditions:
Gastroesophageal Reflux
Eligibility:
All Genders
1-15 years
Phase:
PHASE4
Brief Summary
Proton pump inhibitors are administered to children as off-label use in Japan. The purpose of this study is to evaluate the effects of CYP2C19 genotypes on pharmacokinetic /pharmacodynamic profiles of...
Eligibility Criteria
Inclusion
- Patients with gastroesophageal reflux
- The patient's parent or guardian gives written informed consent including pharmacogenomic analysis
- The patient is willing and able to give assent to participate.
Exclusion
- Serious hepatic disease, pulmonary disease, renal disease and blood disorder
- Inadequate clinical conditions
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00299845
Last Update
October 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka University Hospital
Suita, Osaka, Japan, 565-0871